Regenerative implants for stabilizing the spine and devices for attachment of said implants

Abstract
The invention comprises flat, porous, bioabsorbable implants that are conducive to tissue ingrowth at spinal implantation site, and once absorbed, leave behind a functional ligamentous structure. A preferred material is small intestinal submucosa. Also disclosed are anchoring devices for attaching said implants to the vertebral bodies.
Description
FIELD OF THE INVENTION

This invention is directed to implants and attachment devices for said implants directed toward stabilizing the spine following surgical procedures and that encourage regeneration of a natural anterior longitudinal ligament and interspinous ligaments replacement.


BACKGROUND

Destabilization of the lumbar spine results from sacrifice of the anterior longitudinal ligament and disc when removed for graft or cage placement. Similarly, transection of the interspinous ligaments during surgical approaches to the posterior spine may result in instability. Such instability may cause abnormal motion or implant migration resulting in a high incidence of pseudarthrosis.


In anterior interbody surgical procedures, the anterior longitudinal ligament is sacrificed, resulting in instability which can lead to hyperextension and interbody device migration.


Current anterior spinal interbody fusion procedures are performed either standalone, using a buttress plate or using anterolateral or posterior rigid fixation. Interbody motion devices are implanted without augmenting the device, since no device is available that can provide stability and containment yet allow for normal range of motion. This is a particularly challenging problem when dealing with the normal range of movement of the spine.


U.S. Pat. No. 5,681,310 “Yuan” discloses a holding mat for preventing a foreign object from jutting out of the vertebra. The mat is attached using a plurality of fastening elements and all components are capable of being assimilated into the tissues of a human body. However, the device is not specifically designed to facilitate regeneration of a mechanically appropriate repair tissue, but only to contain foreign objects within the vertebra.


U.S. Pat. No. 6,371,990, “Ferree”, discloses a flexible, biocompatible material that is attached to adjacent vertebral bodies for the purpose of fortifying the annulus fibrosis. The device is used in conjunction with a device for covering the inner wall of the annulus. Ferree discloses using treated pig intestine combined with the invention to promote tissue ingrowth. However, the device is not specifically designed to facilitate regeneration of a mechanically appropriate repair tissue.


U.S. Pat. No. 6,221,109, “Geistlich”, discloses a collagen membrane wrapped around the vertebrae and disc for protection of the spinal cord from implants jutting out of the disc space. The device is used in conjunction with a collagen membrane wrapped around the spinal cord. The device is not specifically designed to facilitate regeneration of a mechanically appropriate repair tissue and appears to be limited to the posterior aspect of the spine surrounding the spinal cord.


U.S. Pat. No. 6,093,205, “McLeod”, discloses a fabric element attached to adjacent vertebrae for the purpose of retaining a specific disc prosthesis described in the invention. The fabric may be made of a resorbable material and may have structure and/or properties to encourage tissue ingrowth. The fabric may be attached using sutures, staples, and bone screws. The device is not specifically designed to facilitate regeneration of a mechanically appropriate repair tissue and is disclosed as an integral part of the disc prosthesis described.


U.S. Pat. No. 5,372,821, “Badylak”, discloses a method for promoting autogenous regrowth of damaged or diseased ligaments by attaching small intestinal submucosa. No mention is made to spinal ligaments, attachment thereof to the spine, or as an augmentation to an intervertebral disc surgical therapy. Similarly, U.S. Pat. No. 5,922,028, “Plouhar”, discloses a tissue graft construct for repairing or replacing a cartilaginous structure located between two bones comprising small intestinal submucosa with 50 to 200 layers and thickness of 4-8 mm and sculpted to the proper shape. Although the patent refers to reconstructing the intervertebral disc, no mention is made to regenerating the spinal ligaments, to achieving a mechanically appropriate repair tissue, or as an adjunct to an intervertebral disc surgical therapy.


Thus there is a need in the art for bioabsorbable, anterior longitudinal ligament and interspinous ligament replacement implants that serve to restore stability following surgical removal of the native ligaments, contain intervertebral body devices or grafts, and encourage regeneration of a functional repair tissue for long-term stability such as described in this invention.





BREIF DESCRIPTION OF THE DRAWINGS

The invention will be more fully understood from the following detailed description taken in conjunction with the accompanying drawings, in which:



FIG. 1 depicts use of the implant of the invention for forming a natural spinal ligament; and



FIG. 2 depicts a suitable anchor device for the invention.





SUMMARY OF THE INVENTION

One aspect of this invention relates to a method for promoting autogenous regrowth and healing of resected, damaged or diseased spinal ligaments comprising the step of surgically repairing said structures by securing one end of an implant to a first spinal vertebrae, transversing the intervertebral space and securing a second end of the implant to a second vertebra, said implant formed from a material that encourages regeneration of a ligament or tendon replacement.


Another aspect of this invention relates to a spinal ligament or tendon implant comprising a material that encourages regeneration of a ligament or tendon.


Yet a further aspect of the invention relates to an anchoring device which a flexible head having a radius of curvature that insures intimate contact between the implant and the tissue that the implant is being attached to.


DETAILED DESCRIPTION OF THE INVENTION

The disclosed invention serves a multitude of purposes for augmenting interbody device implantation for the spine, including: 1) providing initial stability to motion segment, 2) preventing interbody device migration by means of both a physical barrier and as a tension band, and 3) having a physical and chemical structure conducive to assisting the body in regenerating a mechanically appropriate repair tissue.


Devices of the proposed invention are preferably porous, thereby acting as a scaffold for cells to occupy and produce extracellular matrix. The cells may migrate from the surroundings following implantation or be seeded onto the porous device prior to implantation. Alternatively, the cells may be cultured on the porous device for a period of time prior to implantation. Alternatively, bioactive factors may be adsorbed onto or absorbed into the porous device prior to implantation.


Examples of suitable cells include cells harvested from ligaments in the body. Preferably, the cells are obtained from spinal ligaments such as the anterior longitudinal ligament and the posterior interspinous ligaments. Other examples include but are not limited to: stem cells, fibrocytes, adipocytes and chondrocytes.


Examples of suitable bioactive factors include but are not limited to transforming growth factor-beta and agents in the same family of growth factors, platelet-derived growth factors, fibroblast growth factors, insulin-like growth factors, protein polymers such as RGD-peptides and Indian Hedgehog proteins, anti-inflammatory agents, hormones, hyaluronic acid and the like.


Implants of the proposed invention are also preferably susceptible to breaking down after implantation, thereby acting as a temporary support structure for tissue regeneration and resulting in a primarily native repair tissue structure. Preferably the breakdown products of the invention are easily processed by the body through normal metabolic pathways.


Preferred materials of this invention include collagen, hyaluronic acid, elastin, synthetic polymers such as polylactide, polyglycolide and copolymers thereof. In one preferred embodiment of this invention, the porous device is a textile structure comprised of drawn fibers of the aforementioned materials. In a more preferred embodiment, the fibers are woven or braided into the appropriate scaffold structure mentioned.


A preferred collagen material of this invention is small intestinal submucosa (SIS) which is a naturally occurring extracellular collagen based matrix. SIS is described in detail in U.S. Pat. No. 5,372,821, the disclosure of which is hereby incorporated by reference. As described in the '821 patent, SIS is a segment of intestinal tissue of a warm-blooded vertebrate, said segment comprising the tunica submucosa and basilar tissue of the tunica mucosa, said tunica submucosa and basilar tissue being delaminated from the tunica muscularis and the luminal portion of the tunica mucosa of said segment of intestinal tissue. SIS contains cytokines and growth factors and has been shown to act as a resorbable scaffold in vivo which promotes soft tissue regeneration with little scar tissue formation. SIS can be manufactured in laminated sheets of various sizes and thicknesses for different indications. Successful applications of SIS have included: dural substitution, rotator cuff repair, tendinosis, vessel repair, abdominal and bladder wall repair, and others. However, prior to investigations initiated and directed by the inventors, SIS is not known to have been investigated to determine its ability to facilitate regeneration of spinal ligaments.


We have found that the strength of the spinal ligament is controlled by the layering of the SIS. For example, we have performed tensile testing to show that by orienting all layers of the SIS patch in the same direction, a higher ultimate strength can be achieved. When 20 layers were stacked up changing the orientation 72° with each layer (“isotropic”), the ultimate tensile strength was 282 N for a 20 mm wide patch. When all 20 layers were stacked with the same orientation and tested in the direction of higher strength, the ultimate strength was 353 N. Thus the number and orientation of the layers may be adjusted to achieve various tensile strengths depending on the vertebrae to be attached. For example, tensile strengths of 10 N for cervical, 300 N for thoracic, and 450 N for lumbar ligaments are achievable.


The invention may be applied to the spine using any one or more of a variety of attachment means. Such attachment means include but are not limited to adhesives, sutures, suture anchors, soft tissue anchors, staples, and screw/washer systems. In a preferred embodiment of this invention, the device is attached to the anterior aspect of adjacent level vertebral bodies following surgical treatment of the intervertebral space. Thus referring to FIG. 1, implant 10 is shown to bridge the intervertebral space 20 which lies between vertebral body 30 and vertebral body 40. Anchor devices 50 are shown to penetrate implant 10 and vertebral bodies 30 and 40, respectively. In a preferred embodiment, existing spinous ligament tissue 60 is intimately contacted with implant.


In another aspect of this invention, the anchoring devices 50 include as part of their design a head that comes in intimate contact with implant 10 upon final seating of the anchor device 50. FIG. 2 shows a schematic representation of one embodiment of the anchor design. Referring to FIG. 2, anchor device 50 comprises shaft 52 and head 54. Head 54 preferably has a radius of curvature (R) and flexibility such that upon final anchoring, implant 10 is compressed substantially between head 54 of the anchor and the vertebral body. In another more preferred embodiment, the underside surface 56 of head 54 in contact with implant 10 includes grooves or a roughened pattern to increase holding strength.


EXAMPLE

The following example demonstrates the efficacy of SIS to restore stability in the spine and to act as a scaffold for regeneration of the anterior longitudinal ligament (ALL) and interspinous ligaments (ISL) in a goat model.


Four skeletally mature nubian-alpine cross-bred goats were used in this study. Under general anesthesia, each T10 to L5 motion segment was exposed surgically. Both an anteriolateral and posterior approach were made at each level.


Anteriorly, every other level received either: anterior discectomy, sacrifice of ALL, and placement of SIS; anterior discectomy, sacrifice of ALL, and no SIS (“Control”); or sham operation (“Sham”). A solid interbody spacer was placed into the disc space at each SIS and control level to prohibit spontaneous anterior interbody fusion. A sheet of SIS was applied to the ventral surface of each SIS level such that it spanned the disc space making intimate contact with the remaining ALL superiorly and inferiorly. The SIS was secured to the cranial and caudal vertebral bodies with bone staples, suture anchors, and suture.


Posteriorly, every other level received either: sacrifice of the ISL with placement of SIS (“SIS”); sacrifice of ISL and no SIS (“Control”); or sham operation (“Sham”). At SIS levels, a sheet of SIS was applied dorsal to the spinous processes and wrapped over the left and right lateral aspect. The SIS was secured to the spinous processes with suture anchors. Sutures were passed through the SIS and around the adjacent spinous processes to create a tension-band effect.


Animals were radiographed immediately post-operatively to confirm implant placement and to serve as a baseline for interbody spacer positioning. Following surgery, all animals were allowed unrestricted motion for twelve weeks. At the end of the twelve week period, animals were radiographed and euthanized.


The lumbar spine was harvested en bloc and processed for decalcified histologic evaluation. The dorsal and ventral aspects of each motion segment were analyzed for signs of inflammation and scar tissue formation, residual SIS, and regenerated ALL or ISL.


The results showed that animals tolerated the surgical procedure well and there were no intraoperative or anesthesia related complications. Immediate post-operative radiographs showed proper placement of all implants.


Gross analysis at necropsy indicated iatrogenic scar formation, the degree of which was not different from controls to SIS levels. Histologic evaluation of areas where the ALL had been removed indicated formation of organized fibrillar collagenous tissue which spanned the disc space at some levels where the SIS was placed. The newly formed tissue was approximately 70% the thickness of the ALL at the sham level. The newly formed collagenous tissue was accompanied by sparse focal areas of inflammation and no residual SIS at some levels. At control levels, there was limited formation of sparsely organized connective tissues. At sham levels, normal ligamentous structures were present. Similarly, histologic analysis of some levels where SIS was placed posteriorly showed formation of organized collagenous tissues where the ISL had been removed.


Thus, placement of the SIS resulted in regeneration of the ligamentous-like tissues in the spine to a varying degree with limited signs of inflammation and scar formation. This result indicates the potential for SIS in repair of spinal ligaments for restabilization of the lumbar spine.

Claims
  • 1. A method for promoting autogenous regrowth and healing of resected, damaged or diseased spinal ligaments comprising the steps of: surgically repairing a spinal ligament by securing a first end of an implant to a first vertebra, transversing the intervertebral space and securing a second end of the implant to a second vertebra, said implant being formed from a material that encourages regeneration of a ligament or tendon replacement;wherein the material is formed from a segment of intestinal tissue of a warm-blooded vertebrate, said segment comprising one of the tunica submucosa and basilar tissue of the tunica mucosa, said tunica submucosa and basilar tissue being delaminated from the tunica muscularis and the luminal portion of the tunica mucosa of said segment of intestinal tissue; andwherein the step of securing the first end of the implant to a first vertebra comprises attaching the first end of the implant to a portion of an existing spinous ligament tissue and the first vertebra.
  • 2. The method of claim 1, wherein the spinal ligament is an anterior longitudinal ligament.
  • 3. The method of claim 1, wherein the spinal ligament is an interspinous ligament.
  • 4. The method of claim 1, wherein the attaching step comprises penetrating a distal end of an anchor through the first end of the implant, through the portion of the existing spinous ligament tissue and into the first vertebra.
  • 5. The method of claim 4, wherein the anchor has a head and the attaching step comprises the step of contacting the first end of the implant with the head of the anchor.
  • 6. The method of claim 4, further comprising the step of compressing the first end of the implant between the anchor and the first vertebra.
  • 7. The method of claim 1, wherein the attaching step comprises attaching the first end of the implant to an anterior aspect of the first vertebra.
  • 8. The method of claim 1, wherein the attaching step comprises the step of contacting the portion of the existing spinous ligament tissue with the first end of the implant.
  • 9. The method of claim 1, wherein the portion of the existing ligament is a resected end of the resected, damaged or diseased spinal ligament.
  • 10. The method of claim 4, wherein the step of securing the second end of the implant to a second vertebra comprises attaching the second end of the implant to a portion of an existing spinous ligament tissue and the second vertebra.
  • 11. The method of claim 10, wherein the attaching step comprises penetrating a distal end of a second anchor through the second end of the implant, through the portion of the existing spinous ligament tissue and into the second vertebra.
US Referenced Citations (260)
Number Name Date Kind
1105105 Sherman Jul 1914 A
2143910 Didusch Jan 1939 A
3054406 Usher Sep 1962 A
3272204 Artandi Sep 1966 A
3463158 Schmitt et al. Aug 1969 A
3513484 Hausner May 1970 A
3710789 Ersek Jan 1973 A
3741205 Markolfe Jun 1973 A
3848601 Ma et al. Nov 1974 A
4127902 Homsy Dec 1978 A
4255820 Rothermel et al. Mar 1981 A
4403606 Woo et al. Sep 1983 A
4409968 Drummond Oct 1983 A
4411259 Drummond Oct 1983 A
4512038 Alexander Apr 1985 A
4570623 Ellison et al. Feb 1986 A
4599086 Doty Jul 1986 A
4610688 Silvestrini et al. Sep 1986 A
4633873 Dumican et al. Jan 1987 A
4641636 Cotrel Feb 1987 A
4665951 Ellis May 1987 A
4728329 Mansat Mar 1988 A
4743260 Burton May 1988 A
4755183 Kenna Jul 1988 A
4772287 Ray et al. Sep 1988 A
4773406 Spector et al. Sep 1988 A
4781183 Casey et al. Nov 1988 A
4792336 Hlavacek et al. Dec 1988 A
4815453 Cotrel Mar 1989 A
4820305 Harms et al. Apr 1989 A
4834755 Silvestrini et al. May 1989 A
4883486 Kapadia et al. Nov 1989 A
4902508 Badylak et al. Feb 1990 A
4904260 Ray et al. Feb 1990 A
4905680 Tunc Mar 1990 A
4917700 Aikins Apr 1990 A
4956178 Badylak et al. Sep 1990 A
4987892 Krag et al. Jan 1991 A
4995911 Matsumoto et al. Feb 1991 A
5002576 Fuhrmann et al. Mar 1991 A
5011484 Breard Apr 1991 A
5013315 Barrows May 1991 A
5022855 Jeckel Jun 1991 A
5024669 Peterson et al. Jun 1991 A
5049155 Bruchman et al. Sep 1991 A
5074864 Cozad et al. Dec 1991 A
5084049 Asher et al. Jan 1992 A
5084051 Tormala et al. Jan 1992 A
5092866 Bread et al. Mar 1992 A
5102421 Anspack, Jr. Apr 1992 A
5108395 Laurain Apr 1992 A
5112332 Cozad et al. May 1992 A
5116334 Cozad et al. May 1992 A
5139520 Rosenberg Aug 1992 A
5147359 Cozad et al. Sep 1992 A
5147361 Ojima et al. Sep 1992 A
5152303 Allen Oct 1992 A
5154718 Cozad et al. Oct 1992 A
5156616 Meadows et al. Oct 1992 A
5157111 Pachence Oct 1992 A
5171273 Silver et al. Dec 1992 A
5171279 Mathews Dec 1992 A
5180381 Aust et al. Jan 1993 A
5180393 Commarmond Jan 1993 A
5197983 Berman et al. Mar 1993 A
5201734 Cozad et al. Apr 1993 A
5209751 Farris et al. May 1993 A
5222987 Jones Jun 1993 A
5234431 Keller Aug 1993 A
5242443 Kambin Sep 1993 A
5261913 Marnay Nov 1993 A
5269783 Sander Dec 1993 A
5281422 Badylak et al. Jan 1994 A
5306308 Gross et al. Apr 1994 A
5324290 Zdeblick et al. Jun 1994 A
5330473 Howland Jul 1994 A
5344421 Crook Sep 1994 A
5346492 Morgan Sep 1994 A
5352224 Westermann Oct 1994 A
5352463 Badylak et al. Oct 1994 A
5372821 Badylak Dec 1994 A
5376188 Tahara et al. Dec 1994 A
5380324 Muller et al. Jan 1995 A
5380328 Morgan Jan 1995 A
5384149 Lin Jan 1995 A
5397359 Mittelmeier et al. Mar 1995 A
5405391 Hednerson et al. Apr 1995 A
5415661 Holmes May 1995 A
5437672 Alleyne Aug 1995 A
5443483 Kirsch Aug 1995 A
5453227 Rieger Sep 1995 A
5456722 McLeod et al. Oct 1995 A
5462478 Fredsby Oct 1995 A
5496372 Hamamoto et al. Mar 1996 A
5527311 Procter et al. Jun 1996 A
5531745 Ray Jul 1996 A
5531747 Ray Jul 1996 A
5531751 Schultheiss Jul 1996 A
5534031 Matsuzaki et al. Jul 1996 A
5536274 Neuss Jul 1996 A
5540703 Barker, Jr. et al. Jul 1996 A
5540964 Mallen Jul 1996 A
5549612 Yapp et al. Aug 1996 A
5549679 Kuslich Aug 1996 A
5558674 Heggeness et al. Sep 1996 A
5562736 Ray et al. Oct 1996 A
5571109 Bertagnoli Nov 1996 A
5573784 Badylak et al. Nov 1996 A
5980482 Jobe Jan 1997 A
5601554 Howland et al. Feb 1997 A
5603713 Aust et al. Feb 1997 A
5609634 Voydeville Mar 1997 A
5616142 Yuan et al. Apr 1997 A
5616144 Yapp et al. Apr 1997 A
5628756 Barker, Jr. et al. May 1997 A
5634926 Jobe Jun 1997 A
5634944 Magram Jun 1997 A
5641518 Badylak et al. Jun 1997 A
5643261 Schafer et al. Jul 1997 A
5645596 Kim et al. Jul 1997 A
5647872 Gilbert et al. Jul 1997 A
5674295 Ray et al. Oct 1997 A
5674296 Bryan et al. Oct 1997 A
5676666 Oxland et al. Oct 1997 A
5676703 Gelbard Oct 1997 A
5681310 Yuan et al. Oct 1997 A
5681311 Foley et al. Oct 1997 A
5683391 Boyd Nov 1997 A
5693099 Harle Dec 1997 A
5702453 Rabbe et al. Dec 1997 A
5709683 Bagby Jan 1998 A
5709686 Talosef et al. Jan 1998 A
5711960 Shikinami Jan 1998 A
5711969 Patel et al. Jan 1998 A
5716409 Debbas Feb 1998 A
5721049 Marcolongo et al. Feb 1998 A
5728097 Mathews Mar 1998 A
5728127 Asher et al. Mar 1998 A
5735899 Schwartz et al. Apr 1998 A
5741253 Michelson Apr 1998 A
5755791 Whitson et al. May 1998 A
5766176 Duncan Jun 1998 A
5766254 Gelbard Jun 1998 A
5776196 Matsuzaki et al. Jul 1998 A
5785713 Jobe Jul 1998 A
5788625 Plouhar et al. Aug 1998 A
5797917 Boyd et al. Aug 1998 A
5800543 McLeon et al. Sep 1998 A
5824093 Ray et al. Oct 1998 A
5846484 Scarborough et al. Dec 1998 A
5857995 Thomas et al. Jan 1999 A
5865846 Bryan et al. Feb 1999 A
5868745 Alleyne Feb 1999 A
5876452 Athanasiou et al. Mar 1999 A
5885287 Bagby Mar 1999 A
5885619 Patel et al. Mar 1999 A
5888221 Gelbard Mar 1999 A
5888223 Bray, Jr. Mar 1999 A
5899902 Brown et al. May 1999 A
5904683 Pohndorf et al. May 1999 A
5906828 Cima et al. May 1999 A
5919234 Lemperle et al. Jul 1999 A
5922026 Chin Jul 1999 A
5922028 Plouhar et al. Jul 1999 A
5925056 Thomas et al. Jul 1999 A
5955110 Patel et al. Sep 1999 A
5962427 Goldstein et al. Oct 1999 A
5968096 Whitson et al. Oct 1999 A
5972368 McKay Oct 1999 A
5997575 Whitson et al. Dec 1999 A
6010502 Bagby Jan 2000 A
6017345 Richelsoph Jan 2000 A
6022376 Assell et al. Feb 2000 A
6030389 Wagner et al. Feb 2000 A
6031148 Hayes et al. Feb 2000 A
6042534 Gellman et al. Mar 2000 A
6045552 Zucherman et al. Apr 2000 A
6045554 Grooms et al. Apr 2000 A
6077076 Comfort Jun 2000 A
6086589 Kuslich et al. Jul 2000 A
6090998 Grooms et al. Jul 2000 A
6093205 McLeod et al. Jul 2000 A
6099568 Simonian et al. Aug 2000 A
6113640 Tormala et al. Sep 2000 A
6120503 Michelson Sep 2000 A
6121172 Marcolongo et al. Sep 2000 A
6127596 Brown et al. Oct 2000 A
6129730 Bono et al. Oct 2000 A
6136001 Michelson Oct 2000 A
6136002 Shih et al. Oct 2000 A
6139550 Michelson Oct 2000 A
6139551 Michelson et al. Oct 2000 A
6143036 Comfort Nov 2000 A
RE37005 Michelson et al. Dec 2000 E
6156067 Bryan et al. Dec 2000 A
6159213 Rogozinski Dec 2000 A
6162537 Martin et al. Dec 2000 A
6187009 Herzog et al. Feb 2001 B1
6193721 Michelson Feb 2001 B1
6197036 Tripp et al. Mar 2001 B1
6206881 Frigg et al. Mar 2001 B1
6206931 Cook et al. Mar 2001 B1
6221109 Geistlich Apr 2001 B1
6228085 Theken et al. May 2001 B1
6273889 Richelsoph Aug 2001 B1
6290703 Ganem Sep 2001 B1
6293949 Justis et al. Sep 2001 B1
6296643 Hopf et al. Oct 2001 B1
6299613 Ogilvie et al. Oct 2001 B1
6302883 Bono Oct 2001 B1
6306136 Baccelli Oct 2001 B1
6306139 Fuentes Oct 2001 B1
6306170 Ray Oct 2001 B2
6312431 Asfora Nov 2001 B1
6312474 Francis et al. Nov 2001 B1
6328738 Suddaby Dec 2001 B1
6332894 Stalcup et al. Dec 2001 B1
6334872 Termin et al. Jan 2002 B1
6358284 Fearnot et al. Mar 2002 B1
6371990 Ferree Apr 2002 B1
6398783 Michelson Jun 2002 B1
6423065 Ferree Jul 2002 B2
6432140 Lin Aug 2002 B1
6440444 Boyce et al. Aug 2002 B2
6475219 Shelokov Nov 2002 B1
6475232 Babbs et al. Nov 2002 B1
6485723 Badylak et al. Nov 2002 B1
6497726 Carter et al. Dec 2002 B1
6554852 Oberlander Apr 2003 B1
6562073 Foley May 2003 B2
6576017 Foley et al. Jun 2003 B2
6616694 Hart Sep 2003 B1
6616698 Scarborough Sep 2003 B2
6752831 Sybert et al. Jun 2004 B2
6893462 Buskirk et al. May 2005 B2
20010014807 Wagner et al. Aug 2001 A1
20010018614 Bianchi Aug 2001 A1
20010020185 Ray Sep 2001 A1
20010031254 Bianchi et al. Oct 2001 A1
20010041894 Campbell et al. Nov 2001 A1
20020007218 Cauthen Jan 2002 A1
20020010466 Alleyne Jan 2002 A1
20020013586 Justis et al. Jan 2002 A1
20020038151 Plouhar et al. Mar 2002 A1
20020045898 Freid et al. Apr 2002 A1
20020058939 Wagner et al. May 2002 A1
20020068975 Teitelbaum et al. Jun 2002 A1
20020072806 Buskirk et al. Jun 2002 A1
20020077630 Lin Jun 2002 A1
20020107570 Sybert et al. Aug 2002 A1
20020107571 Foley Aug 2002 A1
20020107572 Foley et al. Aug 2002 A1
20020111688 Cauthen Aug 2002 A1
20020120270 Trieu et al. Aug 2002 A1
20020120337 Cauthen Aug 2002 A1
20020123807 Cauthen, III Sep 2002 A1
20020143329 Serhan Oct 2002 A1
20020161449 Muschler Oct 2002 A1
20030036800 Meredith Feb 2003 A1
20030036801 Schwartz et al. Feb 2003 A1
Foreign Referenced Citations (26)
Number Date Country
29 14 164 Oct 1979 DE
4201043 Jul 1993 DE
0 050 162 Apr 1986 EP
0 304 305 May 1992 EP
0 353 936 Nov 1992 EP
0542004 May 1993 EP
0 507 162 Mar 1994 EP
0599766 Jun 1994 EP
0 520 177 Dec 1995 EP
2 612 392 Sep 1988 FR
87 044187 Sep 1988 FR
2 709 410 Mar 1995 FR
WO 9007304 Jul 1990 WO
WO 9106249 May 1991 WO
WO 9211819 Jul 1992 WO
WO 9322989 Nov 1993 WO
WO 9421185 Sep 1994 WO
WO 9851226 Nov 1998 WO
WO 9855053 Dec 1998 WO
WO 9947082 Sep 1999 WO
WO 9962439 Dec 1999 WO
WO 0003653 Jan 2000 WO
WO 0059388 Oct 2000 WO
WO 0064365 Nov 2000 WO
WO 0072782 Dec 2000 WO
WO 02056800 Jul 2002 WO
Related Publications (1)
Number Date Country
20040088053 A1 May 2004 US